High liver activity, as observed in clinical studies with 18F-DCFPyL (12) and 18F-PSMA-1007 (13), might impair detection of liver tumors, notably for detection of hepatocellular carcinomas, for which PSMA imaging may be of value (39). This evidence concerns the gene FOLH1 and hepatocellular carcinoma.